Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1015

    1.

    Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.

    Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE.

    Ann Intern Med. 2007 Oct 16;147(8):525-33.PMID: 17938390 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.

    Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE.

    Circulation. 2007 Sep 25;116(13):1497-503. Epub 2007 Sep 10.PMID: 17846285 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Occurrence of venous thromboembolism in women taking low-dose aspirin.

    [No authors listed]

    Ann Intern Med. 2007 Oct 16;147(8):I34. No abstract available. PMID: 17938386 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.

    Eriksson H, Lundström T, Wåhlander K, Clason SB, Schulman S; THRIVE III Investigators.

    Thromb Haemost. 2005 Sep;94(3):522-7.PMID: 16268466 [PubMed - indexed for MEDLINE]Related articles

    5.

    A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

    Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM.

    N Engl J Med. 2009 Apr 30;360(18):1851-61. Epub 2009 Mar 29.PMID: 19329822 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Homocysteine-lowering therapy and risk for venous thromboembolism: a randomized trial.

    Ray JG, Kearon C, Yi Q, Sheridan P, Lonn E; Heart Outcomes Prevention Evaluation 2 (HOPE-2) Investigators.

    Ann Intern Med. 2007 Jun 5;146(11):761-7. Epub 2007 Apr 30.PMID: 17470822 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Estrogen plus progestin and risk of venous thrombosis.

    Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR; Women's Health Initiative Investigators.

    JAMA. 2004 Oct 6;292(13):1573-80.PMID: 15467059 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Risk factors and clinical impact of postoperative symptomatic venous thromboembolism.

    Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, Henke PK.

    J Vasc Surg. 2007 Feb;45(2):335-341; discussion 341-2.PMID: 17264013 [PubMed - indexed for MEDLINE]Related articles

    9.

    Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.

    Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, Scannapieco G, Ambrosio GB, Pesavento R, Cuppini S, Quintavalla R, Agnelli G; AESOPUS Investigators.

    Ann Intern Med. 2009 May 5;150(9):577-85.PMID: 19414836 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

    Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

    JAMA. 2005 Jul 6;294(1):47-55.PMID: 15998890 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.

    Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ.

    Arch Intern Med. 2005 Feb 14;165(3):341-5.PMID: 15710801 [PubMed - indexed for MEDLINE]Related articles

    12.

    Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

    Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S.

    Ann Intern Med. 2000 May 2;132(9):689-96.PMID: 10787361 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

    Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ; PREVENT Investigators.

    N Engl J Med. 2003 Apr 10;348(15):1425-34. Epub 2003 Feb 24.PMID: 12601075 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study.

    Eriksson BI, Lassen MR; PENTasaccharide in HIp-FRActure Surgery Plus Investigators.

    Arch Intern Med. 2003 Jun 9;163(11):1337-42.PMID: 12796070 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).

    Høibraaten E, Qvigstad E, Arnesen H, Larsen S, Wickstrøm E, Sandset PM.

    Thromb Haemost. 2000 Dec;84(6):961-7.PMID: 11154141 [PubMed - indexed for MEDLINE]Related articles

    16.

    The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma.

    Baz R, Li L, Kottke-Marchant K, Srkalovic G, McGowan B, Yiannaki E, Karam MA, Faiman B, Jawde RA, Andresen S, Zeldis J, Hussein MA.

    Mayo Clin Proc. 2005 Dec;80(12):1568-74.PMID: 16342649 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.

    Straczek C, Oger E, Yon de Jonage-Canonico MB, Plu-Bureau G, Conard J, Meyer G, Alhenc-Gelas M, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group.

    Circulation. 2005 Nov 29;112(22):3495-500. Epub 2005 Nov 21.PMID: 16301339 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.

    Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M.

    J Thromb Haemost. 2006 Jun;4(6):1208-14.PMID: 16706961 [PubMed - indexed for MEDLINE]Related articles

    19.

    Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J; American College of Chest Physicians.

    Chest. 2008 Jun;133(6 Suppl):844S-886S.PMID: 18574280 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.

    Simioni P, Tormene D, Prandoni P, Zerbinati P, Gavasso S, Cefalo P, Girolami A.

    Blood. 2002 Mar 15;99(6):1938-42.PMID: 11877263 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data